• Common Traits of all Successful Entrepreneurs

    Share Now4sharesFacebook4Twitter0Google+0Pinterest0Common Traits of all Successful Entrepreneurs By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur Every successful entrepreneur believes in Pareto’s Law more than the law of gravity. Pareto’s Law states that that 80 percent results come from 20 percent causes. Through experience, such entrepreneurs have learned that 20 percent of their actions yield [..]

  • FDA Aproved First Diagnostic Blood Test for Traumatic Brain Injury

    Share Now3sharesFacebook1Twitter2Google+0Pinterest0FDA Aproved First Diagnostic Blood Test for Traumatic Brain Injury By: Business Wire Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury (TBI), announced that the U.S. Food and Drug Administration (FDA) has granted the De Novo request for the commercialization of Banyan BTITM (Brain Trauma Indicator), [..]

  • Tracking Patients’ Progress With Radio Signals and Machine Learning

    Share Now5sharesFacebook5Twitter0Google+0Pinterest0Tracking Patients’ Progress With Radio Signals and Machine Learning By: Elizabeth Dougherty In 2016, Jason Laramie attended a talk at the Massachusetts Institute of Technology (MIT) about a device that can see through walls. It can detect people, track their movement and breathing, and even see their hearts beating. Laramie, [..]

  • Sandoz Announces US FDA Approval and Launch of Glatopa® for Relapsing Forms of Multiple Sclerosis

    Share Now2sharesFacebook2Twitter0Google+0Pinterest0Sandoz Announces US FDA Approval and Launch of Glatopa® for Relapsing Forms of Multiple Sclerosis By: Novartis News Sandoz, a Novartis division, today announced the US FDA approval and launch of Glatopa® (glatiramer acetate injection) 40 mg/mL. Glatopa (glatiramer acetate injection) 40 mg/mL is FDA-approved as a fully-substitutable, AP-rated generic version of [..]

  • Novartis Receives FDA Approval for Cosentyx® Label Update to Include Moderate-to-Severe Scalp Psoriasis

    Share Now1sharesFacebook1Twitter0Google+0Pinterest0Novartis Receives FDA Approval for Cosentyx® Label Update to Include Moderate-to-Severe Scalp Psoriasis By: Novartis News Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Cosentyx® (secukinumab), the first interleukin-17A (IL-17A) inhibitor approved to treat moderate-to-severe plaque psoriasis[1]. The updated label includes Cosentyx data in [..]

  • 3D Print Shape-Shifting Smart Gel by Rutgers Engineers

    Share Now1sharesFacebook1Twitter0Google+0Pinterest03D Print Shape-Shifting Smart Gel by Rutgers Engineers By: Todd B. Bates | Rutgers University News   Rutgers engineers have invented a “4D printing” method for a smart gel that could lead to the development of “living” structures in human organs and tissues, soft robots and targeted drug delivery. The 4D [..]

  • Flexible Lithium Battery for Wearable Electronics by Columbia Engineers

    Share Now2sharesFacebook2Twitter0Google+0Pinterest0Flexible Lithium Battery for Wearable Electronics by Columbia Engineers By: Columbia University School of Engineering and Applied Science The rapid development of flexible and wearable electronics is giving rise to an exciting range of applications, from smart watches and flexible displays—such as smart phones, tablets, and TV—to smart fabrics, smart glass, [..]

  • A Mutational Timer Is Built Into The Chemistry Of DNA

    Share Now2sharesFacebook2Twitter0Google+0Pinterest0A Mutational Timer Is Built Into The Chemistry Of DNA By: Duke University News If you had to copy billions of letters from one sheet of paper to another, you’d probably make a few mistakes. So it might not come as a surprise that when DNA makes a copy [..]

  • FDA Approved Lutathera® of Novartis for Treatment of Gastroenteropancreatic Neuroendocrine Tumors

    Share Now8sharesFacebook8Twitter0Google+0Pinterest0FDA Approved Lutathera® of Novartis for Treatment of Gastroenteropancreatic Neuroendocrine Tumors By: Novartis Media Release Novartis AG (NYSE: NVS) today announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approval of its new drug application (NDA) for Lutathera® (lutetium Lu 177 [..]

  • Daily Routine of Successful People

    Share Now0sharesFacebook0Twitter0Google+0Pinterest0Daily Routine of Successful People By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur “The secret of your future is hidden in your daily routine.” — Mike Murdock The daily routine of a successful person has the same habits day in and day out. It won’t be easy to make the changes, all [..]

  • New Hassle-Free HIV Test That Works Better and Faster

    Share Now0sharesFacebook0Twitter0Google+0Pinterest0New Hassle-Free HIV Test That Works Better and Faster By: NATHAN COLLINS | Stanford News Public health officials have a tough choice to make when it comes to screening people for HIV: administer a reliable blood test that can detect infections early on, but that few people will volunteer [..]

shares